W.H.O. Backs Antibody Treatment For High-Risk Covid Patients

 14 total views,  1 views today

The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.

From: New York Times